Suppr超能文献

抗高血压的黎巴嫩本土植物:民族药理学和临床试验。

Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial.

机构信息

Lebanese International University, Beirut, P.O. Box 146404, Lebanon.

Faculty of Health Sciences, Beirut Arab University, Beirut, P.O. Box 11-5020, Lebanon.

出版信息

Biomolecules. 2019 Jul 20;9(7):292. doi: 10.3390/biom9070292.

Abstract

Hypertension is highly prevalent among the Lebanese adult population and is indeed the major cause of mortality in Lebanon. Traditional use of antihypertensive medicinal plants has long been practiced. The aim of this study is to document this traditional knowledge and clinically test the antihypertensive capacity of three of the most commonly used wild plant species , and . Ethno-pharmacological data was collected by personal interviews with herbalists and traditional healers using a semi structured survey questionnaire and assessing relative frequency of citation (RFC). The clinical study was conducted by a randomized, blind, placebo-controlled trial in 29 subjects with mild hypertension distributed in four groups, three plant extract treatments and one placebo. Systolic (SBP) and diastolic blood pressures (DBP) as well as mean arterial blood pressures (MAP) were monitored at weeks 4, 8, 12 and 16 during the treatment with 300 mL/day of plant extract. Results showed that , and exhibited the highest values of RCF (0.95) followed by (0.94), (0.92) and (0.90). The clinical trial revealed dose- and duration-dependent significant reductions in SBP, DBP and MAP of subjects treated with , or . Our findings indicate that extracts of these plants present an effective, safe and promising potential as a phyto-therapuetical approach for the treatment of mild hypertension. More research on the phytochemistry, pharmacological effects and the underlying mechanisms is necessary.

摘要

高血压在黎巴嫩成年人群中发病率很高,确实是黎巴嫩的主要死亡原因。传统上一直使用抗高血压药用植物。本研究旨在记录这种传统知识,并对三种最常用的野生植物进行临床测试, 和 。通过个人访谈草药医生和传统治疗师,使用半结构化调查问卷收集民族药理学数据,并评估相对引用频率(RFC)。临床研究采用随机、盲法、安慰剂对照试验,在 29 名轻度高血压患者中进行,将患者分为四组,接受三种植物提取物治疗和一种安慰剂治疗。在治疗期间每天饮用 300 毫升植物提取物,监测 4、8、12 和 16 周时的收缩压(SBP)、舒张压(DBP)和平均动脉血压(MAP)。结果表明, 、 和 具有最高的 RFC 值(0.95),其次是 (0.94)、 (0.92)和 (0.90)。临床试验显示, 、 或 治疗的患者的 SBP、DBP 和 MAP 呈剂量和时间依赖性显著降低。我们的发现表明,这些植物的提取物具有有效、安全和有前途的潜力,可作为治疗轻度高血压的植物治疗方法。需要进一步研究其植物化学、药理作用和潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48da/6681041/06f2032e735e/biomolecules-09-00292-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验